The new appointments include:
• Adrian Lobontiu, MD, FACS, as medical director
• Philip Macdonald as vice president of healthcare economics, policy and reimbursement
• Mike Zagger as vice president of sales and marketing
“These new appointments reflect our company’s leadership position in the GERD market and our deep commitment to building a balanced commercial organization. Our objective is to provide greater access of the TIF procedure to the medical community and the patients they serve,” said Skip Baldino, president and CEO of EGS.
More articles on gastroenterology:
GI in review: 4 major developments in the past two decades
Dr. Jay Yepuri on the ASGE’s new GERD guidelines
ASGE names 2015-2016 board members
